Cystic fibrosis patients, doctors celebrate FDA's 'life-changing' approval of new treatment
November 02 2019, 08:00
The drug, Trikafta, is expected to be available to 90 percent of cystic fibrosis patients in the U.S.
The drug, Trikafta, is expected to be available to 90 percent of cystic fibrosis patients in the U.S.
Source:
FOX News